GlassScriptPhysician profile
Perry S Agbuya
NPI 1003127507
$2,897.60
in general payments reported to CMS, 2019-2025
20 companies · $205 in 2025
The $205 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $768 · 2020: $317 · 2021: $450 · 2022: $502 · 2023: $321 · 2024: $334 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $631.03 | 2019-2025 | Doc Band |
| Pfizer INC. | $527.54 | 2019-2025 | |
| Tris Pharma INC | $385.33 | 2019-2022 | |
| Glaxosmithkline, LLC. | $302.40 | 2019-2024 | Bexsero |
| Ironshore Pharmaceuticals INC. | $257.79 | 2019-2024 | |
| Sanofi Pasteur INC. | $239.34 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $158.22 | 2019-2024 | Gardasil 9, Vaxneuvance, M-M-R II |
| Aytu Biopharma, INC. | $98.29 | 2020-2025 | |
| Sobi, INC | $54.39 | 2019-2021 | |
| Adlon Therapeutics L.P. | $36.59 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $34.68 | 2021-2023 | Qelbree |
| Modernatx, INC. | $30.50 | 2024 | Moderna Covid-19 Vaccine |
| Verrica Pharmaceuticals INC. | $27.06 | 2025 | Ycanth |
| Photonicare INC | $24.18 | 2025 | Otosight Middle Ear Scope |
| Ultragenyx Pharmaceutical INC. | $18.89 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $18.78 | 2023 | Nexplanon |
| Phadia US INC. | $15.61 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.30 | 2019 | |
| Biogen, INC. | $11.50 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Agbuya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.